Iasis Molecular Sciences Awarded $1.25M for Antimicrobial Catheter Translational Research
Tuesday, January 25, 2022
Iasis Molecular Sciences Corporation (IMSC) has been awarded a $1.25M research grant from the Congressionally Directed Medical Research Program’s Spinal Cord Injury Research Program (CDMRP Spinal Cord Injury Research Program). The CDMRP has funded IMSC’s antimicrobial catheter for a three-year project entitled: “Preclinical Investigations of a Novel Antimicrobial Urinary Catheter for Improving Genitourinary Dysfunction.”
